Age – Related macular degeneration (AMD) is an eye condition that affects the macula, the central part of the retina responsible for sharp, central vision.

It is the leading cause of vision loss among older adults.

AMD typically develops with age and can be classified into two forms: dry AMD and wet AMD. Dry AMD involves the gradual breakdown of light-sensitive cells in the macula, leading to blurred or distorted vision. Wet AMD occurs when abnormal blood vessels grow beneath the macula, causing rapid vision loss.

Symptoms

Dry AMD gradually leads to blurry or distorted vision.
Wet AMD leads to rapid decrease in visual acuity.

Treatment

While there is no cure for AMD, early detection, lifestyle changes, and certain treatments can help slow its progression and preserve vision.

Eye injections, specifically anti-vascular endothelial growth factor (anti-VEGF) injections, are a common treatment for age-related macular degeneration (AMD). Anti-VEGF medications are injected into the eye to block the effects of VEGF, a protein that promotes the growth of these abnormal blood vessels. The injections help reduce the leakage and growth of these vessels, slowing down the progression of AMD and preserving vision.

The injections are performed in an Ophthalmologist’s office and typically require multiple treatments over time to maintain the desired effect. Regular monitoring and follow-up visits are essential for optimal management.